BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33521018)

  • 1. Texture Analysis of
    Fan X; Zhang H; Yin Y; Zhang J; Yang M; Qin S; Zhang X; Yu F
    Front Med (Lausanne); 2020; 7():605746. PubMed ID: 33521018
    [No Abstract]   [Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic classification of solitary pulmonary nodules using support vector machine model based on 2-[18F]fluoro-2-deoxy-D-glucose PET/computed tomography texture features.
    Zhang J; Ma G; Cheng J; Song S; Zhang Y; Shi LQ
    Nucl Med Commun; 2020 Jun; 41(6):560-566. PubMed ID: 32282636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
    Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
    Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the Classification of PCNSL and Brain Metastases by Developing a Machine Learning Model Based on
    Cui C; Yao X; Xu L; Chao Y; Hu Y; Zhao S; Hu Y; Zhang J
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983721
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation Between
    Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J
    Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Texture analysis of FDG PET/CT for differentiating between FDG-avid benign and metastatic adrenal tumors: efficacy of combining SUV and texture parameters.
    Nakajo M; Jinguji M; Nakajo M; Shinaji T; Nakabeppu Y; Fukukura Y; Yoshiura T
    Abdom Radiol (NY); 2017 Dec; 42(12):2882-2889. PubMed ID: 28612161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of
    Altinmakas E; Hobbs BP; Ye H; Grubbs EG; Perrier ND; Prieto VG; Lee JE; Ng CS
    Abdom Radiol (NY); 2017 Feb; 42(2):577-584. PubMed ID: 27665482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative CT density histogram values and standardized uptake values of FDG-PET/CT with respiratory gating can distinguish solid adenocarcinomas from squamous cell carcinomas of the lung.
    Tsubakimoto M; Yamashiro T; Tamashiro Y; Murayama S
    Eur J Radiol; 2018 Mar; 100():108-115. PubMed ID: 29496067
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wang T; Sun H; Guo Y; Zou L
    Mol Imaging; 2019; 18():1536012119856965. PubMed ID: 31198089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic Analysis of Positron-Emission Tomography and Computed Tomography Images to Differentiate between Multiple Myeloma and Skeletal Metastases.
    Mannam P; Murali A; Gokulakrishnan P; Venkatachalapathy E; Venkata Sai PM
    Indian J Nucl Med; 2022; 37(3):217-226. PubMed ID: 36686312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative parameters of static imaging and fast kinetics imaging in
    Meng N; Zhang M; Ren J; Fu F; Xie B; Wu Y; Li Z; Dai B; Li Y; Feng T; Xu T; Wang M
    Quant Imaging Med Surg; 2023 Sep; 13(9):5579-5592. PubMed ID: 37711783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
    Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of
    Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
    Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
    [No Abstract]   [Full Text] [Related]  

  • 17. CT radiomics analysis of lung cancers: Differentiation of squamous cell carcinoma from adenocarcinoma, a correlative study with FDG uptake.
    Tomori Y; Yamashiro T; Tomita H; Tsubakimoto M; Ishigami K; Atsumi E; Murayama S
    Eur J Radiol; 2020 Jul; 128():109032. PubMed ID: 32361604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.
    Park T; Lee S; Park S; Lee E; Pahk K; Rhee S; Cho J; Kim C; Eo JS; Choe JG; Kim S
    Nucl Med Mol Imaging; 2015 Mar; 49(1):42-51. PubMed ID: 25774237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT and FLT-PET/CT for differentiating between lipid-poor benign and malignant adrenal tumours.
    Nakajo M; Jinguji M; Fukukura Y; Kajiya Y; Tani A; Nakajo M; Nakabeppu Y; Arimura H; Nishio Y; Nakamura F; Yoshiura T
    Eur Radiol; 2015 Dec; 25(12):3696-705. PubMed ID: 25925356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
    Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
    Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.